Browse Drug Recalls
1,392 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,392 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,392 FDA drug recalls in 2022.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 4, 2022 | SB-6, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . PGE 60 mcg/mL, Multi-Dose ... | CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action L... | Class II | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| Apr 4, 2022 | Sermorelin Acetate, Lyophilized powder for reconstitution, Multi-Dose vials, ... | CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action L... | Class II | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| Apr 4, 2022 | AT-6, Papaverine 40mg/ml . Phentolamine 4mg/ml . Atropine 0.3mg/ml, Multi-Dos... | CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action L... | Class II | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| Apr 4, 2022 | ST-2, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 100 mcg/mL, 10... | CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action L... | Class II | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| Apr 4, 2022 | BIMIX-3, Papaverine 30 mg/mL . Phentolamine 3 mg/mL, 10 mL Multi-Dose vial, R... | CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action L... | Class II | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| Apr 1, 2022 | Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured ... | Subpotent | Class III | Jubilant Cadista Pharmaceuticals, Inc. |
| Apr 1, 2022 | Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufact... | Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results... | Class II | Mylan Pharmaceuticals Inc |
| Apr 1, 2022 | Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit ... | Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Im... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| Apr 1, 2022 | 23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefille... | Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bro... | Class III | The Ritedose Corporation |
| Apr 1, 2022 | CBD Metered Dose Inhaler (CBD) 5 mg Dose, 1 Metered Dose Inhaler, 100 Metered... | Marketed Without an Approved NDA/ANDA | Class II | Wellness BioSciences |
| Apr 1, 2022 | Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 si... | Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for ... | Class III | SUN PHARMACEUTICAL INDUSTRIES INC |
| Apr 1, 2022 | Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit ... | Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Im... | Class II | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| Mar 31, 2022 | Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-... | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Class II | Lupin Pharmaceuticals Inc. |
| Mar 31, 2022 | Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03... | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Class II | Lupin Pharmaceuticals Inc. |
| Mar 31, 2022 | Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg a) 30... | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Class II | Lupin Pharmaceuticals Inc. |
| Mar 31, 2022 | Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/25 mg a) 30-c... | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Class II | Lupin Pharmaceuticals Inc. |
| Mar 31, 2022 | Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottl... | Presence of foreign substance: Presence of stainless steel particulates in tablets. | Class II | MERCK SHARP & DOHME CORP |
| Mar 31, 2022 | Losartan Potassium Tablets USP, 25 mg, a) 90-count bottles (NDC# 68180-376-03... | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Class II | Lupin Pharmaceuticals Inc. |
| Mar 31, 2022 | Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg a) 30-... | CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits | Class II | Lupin Pharmaceuticals Inc. |
| Mar 30, 2022 | Suave 24-Hour Protection Aerosol Antiperspirant Powder scent, Aluminum Chloro... | Chemical contamination: presence of benzene | Class I | Unilever United States Inc. |
| Mar 30, 2022 | Suave 24-Hour Protection Aerosol Antiperspirant Fresh scent, Aluminum Chloroh... | CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated ... | Class II | Unilever United States Inc. |
| Mar 29, 2022 | Pink Pussycat SENSUAL ENHANCEMENT capsule, 3000mg, 1-count blister card, Manu... | Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared silde... | Class I | Pink Toyz |
| Mar 29, 2022 | Wal-Tussin DM (dextromethorphan HBr/Guaifenesin), 12 FL OZ (354 mL) bottles, ... | Incorrect/Undeclared Excipient: Product contains alcohol | Class III | AptaPharma Inc. |
| Mar 29, 2022 | IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, ... | Presence of Particulate Matter: Product was found to contain silica and iron oxide | Class I | Teva Pharmaceuticals USA Inc |
| Mar 29, 2022 | Mickey Mouse Hand Sanitizer, ethyl alcohol 68%, 2.11 oz./to mL bottle, Best B... | Chemical Contamination; FDA analysis found product to contain methanol | Class I | Best Brands Consumer Products, Inc. |
| Mar 29, 2022 | The Mandalorian Hand Sanitizer, ethyl alcohol 68%, 2.11 oz./60 mL bottles, Be... | Chemical Contamination; FDA analysis found product to contain benzene | Class I | Best Brands Consumer Products, Inc. |
| Mar 28, 2022 | Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delay... | Out of specification results observed in dissolution during long term stability testing. | Class II | Preferred Pharmaceuticals, Inc. |
| Mar 24, 2022 | Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone 120mg, 30 ... | Microbial Contamination of Non-Sterile Products | Class I | Plastikon Healthcare LLC |
| Mar 24, 2022 | MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup, packag... | Microbial Contamination of Non-Sterile Products | Class I | Plastikon Healthcare LLC |
| Mar 24, 2022 | Acetaminophen Oral Solution, USP 650mg/ 20.3 mL cup, packaged in 10 cups per ... | CGMP Deviations: Failure to properly investigate failed microbial testing. | Class II | Plastikon Healthcare LLC |
| Mar 24, 2022 | Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Pre... | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Te... | Class II | Preferred Pharmaceuticals, Inc. |
| Mar 24, 2022 | Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone 120mg, 30 ... | CGMP Deviations: Failure to properly investigate failed microbial testing. | Class II | Plastikon Healthcare LLC |
| Mar 24, 2022 | MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup, packag... | CGMP Deviations: Failure to properly investigate failed microbial testing. | Class II | Plastikon Healthcare LLC |
| Mar 24, 2022 | Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bot... | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Te... | Class II | Preferred Pharmaceuticals, Inc. |
| Mar 23, 2022 | TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged ... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, F... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable,... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, ... | Failed Dissolution Specifications; during long term stability testing. | Class II | Dr. Reddy's Laboratories, Inc. |
| Mar 23, 2022 | TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi ... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx O... | CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Te... | Class II | Preferred Pharmaceuticals, Inc. |
| Mar 23, 2022 | TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML Injectable, Packaged in a multi dos... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 5... | Failed Dissolution Specifications; during long term stability testing. | Class II | Dr. Reddy's Laboratories, Inc. |
| Mar 23, 2022 | TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable, Package... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 23, 2022 | (CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vi... | Lack of sterility assurance. | Class II | Drug Depot, Inc., dba APS Pharmacy |
| Mar 21, 2022 | SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled... | Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephr... | Class I | Adamis Pharmaceuticals Corporation |
| Mar 21, 2022 | SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled ... | Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephr... | Class I | Adamis Pharmaceuticals Corporation |
| Mar 21, 2022 | quinapril and hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets bottles, ... | CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the accepta... | Class II | Pfizer Inc. |
| Mar 21, 2022 | Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Table... | CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit. | Class II | Sandoz, Inc |
| Mar 21, 2022 | quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles... | CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the accepta... | Class II | Pfizer Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.